Amgen's High Court Defeat Leaves Defense Bar Reeling
By rejecting Amgen Inc.'s bid to raise the bar for investors in securities class actions, the U.S. Supreme Court on Wednesday dealt a crushing blow to the defense bar and disappointed...To view the full article, register now.
Already a subscriber? Click here to view full article